Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis
Abstract BACKGROUND Women diagnosed with polycystic ovary syndrome (PCOS) suffer from an unfavorable cardiometabolic risk profile, which is already established by child-bearing age. OBJECTIVE AND RATIONALE The aim of this systematic review along with an individual participant data meta-analysis is t...
Gespeichert in:
Veröffentlicht in: | Human reproduction update 2020-01, Vol.26 (1), p.104-118 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 118 |
---|---|
container_issue | 1 |
container_start_page | 104 |
container_title | Human reproduction update |
container_volume | 26 |
creator | Gunning, Marlise N Sir Petermann, Teresa Crisosto, Nicolas van Rijn, Bas B de Wilde, Marlieke A Christ, Jacob P Uiterwaal, C S P M de Jager, Wilco Eijkemans, Marinus J C Kunselman, Allen R Legro, Richard S Fauser, Bart C J M |
description | Abstract
BACKGROUND
Women diagnosed with polycystic ovary syndrome (PCOS) suffer from an unfavorable cardiometabolic risk profile, which is already established by child-bearing age.
OBJECTIVE AND RATIONALE
The aim of this systematic review along with an individual participant data meta-analysis is to evaluate whether cardiometabolic features in the offspring (females and males aged 1–18 years) of women with PCOS (OPCOS) are less favorable compared to the offspring of healthy controls.
SEARCH METHODS
PubMed, Embase and gray literature databases were searched by three authors independently (M.N.G., M.A.W and J.C.) (last updated on 1 February 2018). Relevant key terms such as ‘offspring’ and ‘PCOS’ were combined. Outcomes were age-specific standardized scores of various cardiometabolic parameters: BMI, blood pressure, glucose, insulin, lipid profile and the sum scores of various cardiometabolic features (metabolic sum score). Linear mixed models were used for analyses with standardized beta (β) as outcome.
OUTCOMES
Nine relevant observational studies could be identified, which jointly included 1367 children: OPCOS and controls, originating from the Netherlands, Chile and the USA. After excluding neonates, duplicate records and follow-up screenings, a total of 885 subjects remained. In adjusted analyses, we observed that OPCOS (n = 298) exhibited increased plasma levels of fasting insulin (β = 0.21(95%CI: 0.01–0.41), P = 0.05), insulin-resistance (β = 0.21(95%CI: 0.01–0.42), P = 0.04), triglycerides (β = 0.19(95%CI: 0.02–0.36), P = 0.03) and high-density lipoprotein (HDL)-cholesterol concentrations (β = 0.31(95%CI: 0.08–0.54), P |
doi_str_mv | 10.1093/humupd/dmz036 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7007319</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/humupd/dmz036</oup_id><sourcerecordid>2330062435</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-bd91053ea23c76e97ebed2cbd6f9d3b67c9a0ff6bf48f0263b1391ad6361c6dd3</originalsourceid><addsrcrecordid>eNqFkctuFDEQRS1ERB6wZIu8ZNOJ3e62p1kgoVF4SJGCBKytaj8yRm67sd0zGj6E78XRDIGsWLnke-tUlS5CLym5pGRgV5tlWmZ9paefhPEn6Ix2nDQt48PTWrO-bzqx4qfoPOfvhFBOV-IZOmV0xQUX_Rn6tYakXZxMgTF6p_DGgC8b7AKO1uY5uXBXK7yrloB3rkqf17dfsIrTDMloXOKxZV__QknR5zcYcN7nYiYolZjM1pkdhqArVbut0wt4XLur6GYIBWsogO9XaCCA32eXn6MTCz6bF8f3An17f_11_bG5uf3waf3uplFdS0oz6oGSnhlomRLcDMKMRrdq1NwOmo1cqAGItXy03cqSlrORsoGC5oxTxbVmF-jtgTsv42S0MvUC8LKePUHaywhOPlaC28i7uJWCEMHoUAGvj4AUfywmFzm5rIz3EExcsmwZI4S3HeurtTlYVYo5J2MfxlAi77OUhyzlIcvqf_Xvbg_uP-H9nR2X-T-s36n7sJE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2330062435</pqid></control><display><type>article</type><title>Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Gunning, Marlise N ; Sir Petermann, Teresa ; Crisosto, Nicolas ; van Rijn, Bas B ; de Wilde, Marlieke A ; Christ, Jacob P ; Uiterwaal, C S P M ; de Jager, Wilco ; Eijkemans, Marinus J C ; Kunselman, Allen R ; Legro, Richard S ; Fauser, Bart C J M</creator><creatorcontrib>Gunning, Marlise N ; Sir Petermann, Teresa ; Crisosto, Nicolas ; van Rijn, Bas B ; de Wilde, Marlieke A ; Christ, Jacob P ; Uiterwaal, C S P M ; de Jager, Wilco ; Eijkemans, Marinus J C ; Kunselman, Allen R ; Legro, Richard S ; Fauser, Bart C J M</creatorcontrib><description>Abstract
BACKGROUND
Women diagnosed with polycystic ovary syndrome (PCOS) suffer from an unfavorable cardiometabolic risk profile, which is already established by child-bearing age.
OBJECTIVE AND RATIONALE
The aim of this systematic review along with an individual participant data meta-analysis is to evaluate whether cardiometabolic features in the offspring (females and males aged 1–18 years) of women with PCOS (OPCOS) are less favorable compared to the offspring of healthy controls.
SEARCH METHODS
PubMed, Embase and gray literature databases were searched by three authors independently (M.N.G., M.A.W and J.C.) (last updated on 1 February 2018). Relevant key terms such as ‘offspring’ and ‘PCOS’ were combined. Outcomes were age-specific standardized scores of various cardiometabolic parameters: BMI, blood pressure, glucose, insulin, lipid profile and the sum scores of various cardiometabolic features (metabolic sum score). Linear mixed models were used for analyses with standardized beta (β) as outcome.
OUTCOMES
Nine relevant observational studies could be identified, which jointly included 1367 children: OPCOS and controls, originating from the Netherlands, Chile and the USA. After excluding neonates, duplicate records and follow-up screenings, a total of 885 subjects remained. In adjusted analyses, we observed that OPCOS (n = 298) exhibited increased plasma levels of fasting insulin (β = 0.21(95%CI: 0.01–0.41), P = 0.05), insulin-resistance (β = 0.21(95%CI: 0.01–0.42), P = 0.04), triglycerides (β = 0.19(95%CI: 0.02–0.36), P = 0.03) and high-density lipoprotein (HDL)-cholesterol concentrations (β = 0.31(95%CI: 0.08–0.54), P < 0.01), but a reduced birthweight (β = −116(95%CI: −195 to 38), P < 0.01) compared to controls (n = 587). After correction for multiple testing, however, differences in insulin and triglycerides lost their statistical significance. Interaction tests for sex revealed differences between males and females when comparing OPCOS versus controls. A higher 2-hour fasting insulin was observed among female OPCOS versus female controls (estimated difference for females (βf) = 0.45(95%CI: 0.07 to 0.83)) compared to the estimated difference between males ((βm) = −0.20(95%CI: −0.58 to 0.19)), with interaction-test: P = 0.03. Low-density lipoprotein–cholesterol differences in OPCOS versus controls were lower among females (βf = −0.39(95%CI: −0.62 to 0.16)), but comparable between male OPCOS and male controls (βm = 0.27(95%CI: −0.03 to 0.57)), with interaction-test: P < 0.01. Total cholesterol differences in OPCOS versus controls were also lower in females compared to the difference in male OPCOS and male controls (βf = −0.31(95%CI: −0.57 to 0.06), βm = 0.28(95%CI: −0.01 to 0.56), interaction-test: P = 0.01). The difference in HDL-cholesterol among female OPCOS versus controls (βf = 0.53(95%CI: 0.18–0.88)) was larger compared to the estimated mean difference among OPCOS males and the male controls (βm = 0.13(95%CI: −0.05−0.31), interaction-test: P < 0.01). Interaction test in metabolic sum score revealed a significant difference between females (OPCOS versus controls) and males (OPCOS versus controls); however, sub analyses performed in both sexes separately did not reveal a difference among females (OPCOS versus controls: βf = −0.14(95%CI: −1.05 to 0.77)) or males (OPCOS versus controls: βm = 0.85(95%CI: −0.10 to 1.79)), with P-value < 0.01.
WIDER IMPLICATIONS
We observed subtle signs of altered cardiometabolic health in OPCOS. Therefore, the unfavorable cardiovascular profile of women with PCOS at childbearing age may—next to a genetic predisposition—influence the health of their offspring. Sensitivity analyses revealed that these differences were predominantly observed among female offspring aged between 1 and 18 years. Moreover, studies with minimal risk of bias should elucidate the influence of a PCOS diagnosis in mothers on both sexes during fetal development and subsequently during childhood.</description><identifier>ISSN: 1355-4786</identifier><identifier>EISSN: 1460-2369</identifier><identifier>DOI: 10.1093/humupd/dmz036</identifier><identifier>PMID: 31867675</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Review</subject><ispartof>Human reproduction update, 2020-01, Vol.26 (1), p.104-118</ispartof><rights>The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. 2019</rights><rights>The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-bd91053ea23c76e97ebed2cbd6f9d3b67c9a0ff6bf48f0263b1391ad6361c6dd3</citedby><cites>FETCH-LOGICAL-c420t-bd91053ea23c76e97ebed2cbd6f9d3b67c9a0ff6bf48f0263b1391ad6361c6dd3</cites><orcidid>0000-0002-6283-2983</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31867675$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gunning, Marlise N</creatorcontrib><creatorcontrib>Sir Petermann, Teresa</creatorcontrib><creatorcontrib>Crisosto, Nicolas</creatorcontrib><creatorcontrib>van Rijn, Bas B</creatorcontrib><creatorcontrib>de Wilde, Marlieke A</creatorcontrib><creatorcontrib>Christ, Jacob P</creatorcontrib><creatorcontrib>Uiterwaal, C S P M</creatorcontrib><creatorcontrib>de Jager, Wilco</creatorcontrib><creatorcontrib>Eijkemans, Marinus J C</creatorcontrib><creatorcontrib>Kunselman, Allen R</creatorcontrib><creatorcontrib>Legro, Richard S</creatorcontrib><creatorcontrib>Fauser, Bart C J M</creatorcontrib><title>Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis</title><title>Human reproduction update</title><addtitle>Hum Reprod Update</addtitle><description>Abstract
BACKGROUND
Women diagnosed with polycystic ovary syndrome (PCOS) suffer from an unfavorable cardiometabolic risk profile, which is already established by child-bearing age.
OBJECTIVE AND RATIONALE
The aim of this systematic review along with an individual participant data meta-analysis is to evaluate whether cardiometabolic features in the offspring (females and males aged 1–18 years) of women with PCOS (OPCOS) are less favorable compared to the offspring of healthy controls.
SEARCH METHODS
PubMed, Embase and gray literature databases were searched by three authors independently (M.N.G., M.A.W and J.C.) (last updated on 1 February 2018). Relevant key terms such as ‘offspring’ and ‘PCOS’ were combined. Outcomes were age-specific standardized scores of various cardiometabolic parameters: BMI, blood pressure, glucose, insulin, lipid profile and the sum scores of various cardiometabolic features (metabolic sum score). Linear mixed models were used for analyses with standardized beta (β) as outcome.
OUTCOMES
Nine relevant observational studies could be identified, which jointly included 1367 children: OPCOS and controls, originating from the Netherlands, Chile and the USA. After excluding neonates, duplicate records and follow-up screenings, a total of 885 subjects remained. In adjusted analyses, we observed that OPCOS (n = 298) exhibited increased plasma levels of fasting insulin (β = 0.21(95%CI: 0.01–0.41), P = 0.05), insulin-resistance (β = 0.21(95%CI: 0.01–0.42), P = 0.04), triglycerides (β = 0.19(95%CI: 0.02–0.36), P = 0.03) and high-density lipoprotein (HDL)-cholesterol concentrations (β = 0.31(95%CI: 0.08–0.54), P < 0.01), but a reduced birthweight (β = −116(95%CI: −195 to 38), P < 0.01) compared to controls (n = 587). After correction for multiple testing, however, differences in insulin and triglycerides lost their statistical significance. Interaction tests for sex revealed differences between males and females when comparing OPCOS versus controls. A higher 2-hour fasting insulin was observed among female OPCOS versus female controls (estimated difference for females (βf) = 0.45(95%CI: 0.07 to 0.83)) compared to the estimated difference between males ((βm) = −0.20(95%CI: −0.58 to 0.19)), with interaction-test: P = 0.03. Low-density lipoprotein–cholesterol differences in OPCOS versus controls were lower among females (βf = −0.39(95%CI: −0.62 to 0.16)), but comparable between male OPCOS and male controls (βm = 0.27(95%CI: −0.03 to 0.57)), with interaction-test: P < 0.01. Total cholesterol differences in OPCOS versus controls were also lower in females compared to the difference in male OPCOS and male controls (βf = −0.31(95%CI: −0.57 to 0.06), βm = 0.28(95%CI: −0.01 to 0.56), interaction-test: P = 0.01). The difference in HDL-cholesterol among female OPCOS versus controls (βf = 0.53(95%CI: 0.18–0.88)) was larger compared to the estimated mean difference among OPCOS males and the male controls (βm = 0.13(95%CI: −0.05−0.31), interaction-test: P < 0.01). Interaction test in metabolic sum score revealed a significant difference between females (OPCOS versus controls) and males (OPCOS versus controls); however, sub analyses performed in both sexes separately did not reveal a difference among females (OPCOS versus controls: βf = −0.14(95%CI: −1.05 to 0.77)) or males (OPCOS versus controls: βm = 0.85(95%CI: −0.10 to 1.79)), with P-value < 0.01.
WIDER IMPLICATIONS
We observed subtle signs of altered cardiometabolic health in OPCOS. Therefore, the unfavorable cardiovascular profile of women with PCOS at childbearing age may—next to a genetic predisposition—influence the health of their offspring. Sensitivity analyses revealed that these differences were predominantly observed among female offspring aged between 1 and 18 years. Moreover, studies with minimal risk of bias should elucidate the influence of a PCOS diagnosis in mothers on both sexes during fetal development and subsequently during childhood.</description><subject>Review</subject><issn>1355-4786</issn><issn>1460-2369</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNqFkctuFDEQRS1ERB6wZIu8ZNOJ3e62p1kgoVF4SJGCBKytaj8yRm67sd0zGj6E78XRDIGsWLnke-tUlS5CLym5pGRgV5tlWmZ9paefhPEn6Ix2nDQt48PTWrO-bzqx4qfoPOfvhFBOV-IZOmV0xQUX_Rn6tYakXZxMgTF6p_DGgC8b7AKO1uY5uXBXK7yrloB3rkqf17dfsIrTDMloXOKxZV__QknR5zcYcN7nYiYolZjM1pkdhqArVbut0wt4XLur6GYIBWsogO9XaCCA32eXn6MTCz6bF8f3An17f_11_bG5uf3waf3uplFdS0oz6oGSnhlomRLcDMKMRrdq1NwOmo1cqAGItXy03cqSlrORsoGC5oxTxbVmF-jtgTsv42S0MvUC8LKePUHaywhOPlaC28i7uJWCEMHoUAGvj4AUfywmFzm5rIz3EExcsmwZI4S3HeurtTlYVYo5J2MfxlAi77OUhyzlIcvqf_Xvbg_uP-H9nR2X-T-s36n7sJE</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Gunning, Marlise N</creator><creator>Sir Petermann, Teresa</creator><creator>Crisosto, Nicolas</creator><creator>van Rijn, Bas B</creator><creator>de Wilde, Marlieke A</creator><creator>Christ, Jacob P</creator><creator>Uiterwaal, C S P M</creator><creator>de Jager, Wilco</creator><creator>Eijkemans, Marinus J C</creator><creator>Kunselman, Allen R</creator><creator>Legro, Richard S</creator><creator>Fauser, Bart C J M</creator><general>Oxford University Press</general><scope>TOX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6283-2983</orcidid></search><sort><creationdate>20200101</creationdate><title>Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis</title><author>Gunning, Marlise N ; Sir Petermann, Teresa ; Crisosto, Nicolas ; van Rijn, Bas B ; de Wilde, Marlieke A ; Christ, Jacob P ; Uiterwaal, C S P M ; de Jager, Wilco ; Eijkemans, Marinus J C ; Kunselman, Allen R ; Legro, Richard S ; Fauser, Bart C J M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-bd91053ea23c76e97ebed2cbd6f9d3b67c9a0ff6bf48f0263b1391ad6361c6dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gunning, Marlise N</creatorcontrib><creatorcontrib>Sir Petermann, Teresa</creatorcontrib><creatorcontrib>Crisosto, Nicolas</creatorcontrib><creatorcontrib>van Rijn, Bas B</creatorcontrib><creatorcontrib>de Wilde, Marlieke A</creatorcontrib><creatorcontrib>Christ, Jacob P</creatorcontrib><creatorcontrib>Uiterwaal, C S P M</creatorcontrib><creatorcontrib>de Jager, Wilco</creatorcontrib><creatorcontrib>Eijkemans, Marinus J C</creatorcontrib><creatorcontrib>Kunselman, Allen R</creatorcontrib><creatorcontrib>Legro, Richard S</creatorcontrib><creatorcontrib>Fauser, Bart C J M</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Human reproduction update</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gunning, Marlise N</au><au>Sir Petermann, Teresa</au><au>Crisosto, Nicolas</au><au>van Rijn, Bas B</au><au>de Wilde, Marlieke A</au><au>Christ, Jacob P</au><au>Uiterwaal, C S P M</au><au>de Jager, Wilco</au><au>Eijkemans, Marinus J C</au><au>Kunselman, Allen R</au><au>Legro, Richard S</au><au>Fauser, Bart C J M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis</atitle><jtitle>Human reproduction update</jtitle><addtitle>Hum Reprod Update</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>26</volume><issue>1</issue><spage>104</spage><epage>118</epage><pages>104-118</pages><issn>1355-4786</issn><eissn>1460-2369</eissn><abstract>Abstract
BACKGROUND
Women diagnosed with polycystic ovary syndrome (PCOS) suffer from an unfavorable cardiometabolic risk profile, which is already established by child-bearing age.
OBJECTIVE AND RATIONALE
The aim of this systematic review along with an individual participant data meta-analysis is to evaluate whether cardiometabolic features in the offspring (females and males aged 1–18 years) of women with PCOS (OPCOS) are less favorable compared to the offspring of healthy controls.
SEARCH METHODS
PubMed, Embase and gray literature databases were searched by three authors independently (M.N.G., M.A.W and J.C.) (last updated on 1 February 2018). Relevant key terms such as ‘offspring’ and ‘PCOS’ were combined. Outcomes were age-specific standardized scores of various cardiometabolic parameters: BMI, blood pressure, glucose, insulin, lipid profile and the sum scores of various cardiometabolic features (metabolic sum score). Linear mixed models were used for analyses with standardized beta (β) as outcome.
OUTCOMES
Nine relevant observational studies could be identified, which jointly included 1367 children: OPCOS and controls, originating from the Netherlands, Chile and the USA. After excluding neonates, duplicate records and follow-up screenings, a total of 885 subjects remained. In adjusted analyses, we observed that OPCOS (n = 298) exhibited increased plasma levels of fasting insulin (β = 0.21(95%CI: 0.01–0.41), P = 0.05), insulin-resistance (β = 0.21(95%CI: 0.01–0.42), P = 0.04), triglycerides (β = 0.19(95%CI: 0.02–0.36), P = 0.03) and high-density lipoprotein (HDL)-cholesterol concentrations (β = 0.31(95%CI: 0.08–0.54), P < 0.01), but a reduced birthweight (β = −116(95%CI: −195 to 38), P < 0.01) compared to controls (n = 587). After correction for multiple testing, however, differences in insulin and triglycerides lost their statistical significance. Interaction tests for sex revealed differences between males and females when comparing OPCOS versus controls. A higher 2-hour fasting insulin was observed among female OPCOS versus female controls (estimated difference for females (βf) = 0.45(95%CI: 0.07 to 0.83)) compared to the estimated difference between males ((βm) = −0.20(95%CI: −0.58 to 0.19)), with interaction-test: P = 0.03. Low-density lipoprotein–cholesterol differences in OPCOS versus controls were lower among females (βf = −0.39(95%CI: −0.62 to 0.16)), but comparable between male OPCOS and male controls (βm = 0.27(95%CI: −0.03 to 0.57)), with interaction-test: P < 0.01. Total cholesterol differences in OPCOS versus controls were also lower in females compared to the difference in male OPCOS and male controls (βf = −0.31(95%CI: −0.57 to 0.06), βm = 0.28(95%CI: −0.01 to 0.56), interaction-test: P = 0.01). The difference in HDL-cholesterol among female OPCOS versus controls (βf = 0.53(95%CI: 0.18–0.88)) was larger compared to the estimated mean difference among OPCOS males and the male controls (βm = 0.13(95%CI: −0.05−0.31), interaction-test: P < 0.01). Interaction test in metabolic sum score revealed a significant difference between females (OPCOS versus controls) and males (OPCOS versus controls); however, sub analyses performed in both sexes separately did not reveal a difference among females (OPCOS versus controls: βf = −0.14(95%CI: −1.05 to 0.77)) or males (OPCOS versus controls: βm = 0.85(95%CI: −0.10 to 1.79)), with P-value < 0.01.
WIDER IMPLICATIONS
We observed subtle signs of altered cardiometabolic health in OPCOS. Therefore, the unfavorable cardiovascular profile of women with PCOS at childbearing age may—next to a genetic predisposition—influence the health of their offspring. Sensitivity analyses revealed that these differences were predominantly observed among female offspring aged between 1 and 18 years. Moreover, studies with minimal risk of bias should elucidate the influence of a PCOS diagnosis in mothers on both sexes during fetal development and subsequently during childhood.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>31867675</pmid><doi>10.1093/humupd/dmz036</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-6283-2983</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1355-4786 |
ispartof | Human reproduction update, 2020-01, Vol.26 (1), p.104-118 |
issn | 1355-4786 1460-2369 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7007319 |
source | Oxford University Press Journals All Titles (1996-Current); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Review |
title | Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T19%3A10%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiometabolic%20health%20in%20offspring%20of%20women%20with%20PCOS%20compared%20to%20healthy%20controls:%20a%20systematic%20review%20and%20individual%20participant%20data%20meta-analysis&rft.jtitle=Human%20reproduction%20update&rft.au=Gunning,%20Marlise%20N&rft.date=2020-01-01&rft.volume=26&rft.issue=1&rft.spage=104&rft.epage=118&rft.pages=104-118&rft.issn=1355-4786&rft.eissn=1460-2369&rft_id=info:doi/10.1093/humupd/dmz036&rft_dat=%3Cproquest_pubme%3E2330062435%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2330062435&rft_id=info:pmid/31867675&rft_oup_id=10.1093/humupd/dmz036&rfr_iscdi=true |